WeVote
Log In

Bill

Bill

S 817

An Act to ensure access to epinephrine for minors

194th Legislature (2025-2026) Introduced by Patrick Kearney and 1 co-sponsor

Massachusetts bill mandates minors' access to epinephrine in key facilities to prevent deaths from severe allergic reactions.

Committee recommended ought to pass and referred to the committee on Senate Ways and Means
0
WeVote Research Nonpartisan
Bill Summary · S 817

Legislative bill overview

S 817 proposes legislation to guarantee that minors in Massachusetts have access to epinephrine, likely addressing barriers in schools, childcare facilities, or emergency response settings. The bill has progressed through committee review with a favorable report and is currently moving through the healthcare financing review process.

Why is this important

Epinephrine auto-injectors (EpiPens) are life-saving devices for individuals experiencing severe allergic reactions (anaphylaxis), which can be fatal within minutes. Ensuring reliable access for minors—particularly in settings where children spend significant time—can prevent deaths and hospitalizations from allergic emergencies.

Potential points of contention

  • Cost and funding mechanism: Questions about whether schools and facilities will absorb costs, whether insurance must cover it, or if the state will subsidize epinephrine stockpiles
  • Liability and training requirements: Unclear standards for who can administer epinephrine, staff training obligations, and legal protection for administrators in emergency situations
  • Implementation scope: Uncertainty about which facilities are required to maintain supplies (schools only, childcare, sports facilities, etc.) and compliance timelines

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.